2 line items for budesonide/formoterol oral inhalers. Awarded for a base year of 8/7/2026 to 8/6/2027 plus 4 one-year periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0033
- Awardee
-
Mylan Pharmaceuticals Inc. UEI NDN1MYB8DKK5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Budesonide/Formoterol INH Pre-Solicitation · 36E79726R0013 · Posted Mar 24, 2026
- Last date to order 19% complete
- IDV ceiling
- $436,529,695.70
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Mylan Pharmaceuticals Inc. for Budesonide/Formoterol oral inhalers on August 7, 2026, with a ceiling value of $436,529,695.70. The contract carries no set-aside designation and is unrestricted.
The originating solicitation (RFP 36E79726R0013) sought to procure two line items: Budesonide 160mcg/Formoterol Fumarate 4.5mcg/spray inhalers and Budesonide 80mcg/Formoterol Fumarate 4.5mcg/spray inhalers, each in 10.2-gram packages. Annual estimated requirements total 942,316 canisters (722,021 units of the 160/4.5 strength and 220,295 units of the 80/4.5 strength). The procurement was issued in commercial item format under FAR Part 12 and is intended to serve the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers.
The contract runs from August 7, 2026 through August 6, 2027 as the base year, with four one-year option periods extending potential performance through August 6, 2031. The NAICS classification is 325412 (Pharmaceutical Preparation Manufacturing).
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0033?
36E79726D0033 was awarded to Mylan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on August 7, 2026.
How much is contract 36E79726D0033 worth?
36E79726D0033's own ceiling is $436,529,696.
Who can order from contract 36E79726D0033?
36E79726D0033 is a single award indefinite delivery contract.
Was contract 36E79726D0033 competed?
The extent of competition for 36E79726D0033 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV